lorazepam and fluvoxamine

lorazepam has been researched along with fluvoxamine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Anstee, JA; Ashford, JJ; Laws, D	1
Böning, J; Wodarz, N	1
Jean-Baptiste, M; Mukai, Y; Two, A	1

Reviews

1 review(s) available for lorazepam and fluvoxamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for lorazepam and fluvoxamine

Article	Year
A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice. Acta psychiatrica Scandinavica, 1990, Volume: 81, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Family Practice; Female; Fluvoxamine; Humans; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Oximes; Personality Tests; United Kingdom	1990

Article

Year

A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice.

Acta psychiatrica Scandinavica, 1990, Volume: 81, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Family Practice; Female; Fluvoxamine; Humans; Lorazepam; Male; Middle Aged; Multicenter Studies as Topic; Oximes; Personality Tests; United Kingdom

1990

Other Studies

5 other study(ies) available for lorazepam and fluvoxamine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
["Ecstasy"-induced psychotic depersonalization syndrome]. Der Nervenarzt, 1993, Volume: 64, Issue:7 Topics: 3,4-Methylenedioxyamphetamine; Adult; Combined Modality Therapy; Depersonalization; Designer Drugs; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Lorazepam; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Suicide; Suicide Prevention	1993
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. BMJ case reports, 2011, Aug-04, Volume: 2011 Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Dopamine Agents; Female; Fluvoxamine; GABA Modulators; Humans; Lorazepam; Memantine; Neurosurgical Procedures; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors	2011